Keith S Manchester Arbutus Biopharma Corp (ABUS) insider trading activity

Keith S Manchester is Director of Arbutus Biopharma Corp. Currently has a direct ownership of 46,069 shares of ABUS, which is worth approximately $209,613. The most recent transaction as insider was on Aug 14, 2024, when has been sold 8,846 shares (Common Shares) at a price of $3.69 per share, resulting in proceeds of $32,641. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.1K

n/a 3M change

n/a 12M change

Total Value Held $209,613

KEITH S MANCHESTER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Aug 14 2024	SELL Open market or private sale	$32,641 $3.69 p/Share	8,846 Reduced 16.11%	46,069 Common Shares
Aug 14 2024	BUY Exercise of conversion of derivative security	$30,752 $0.56 p/Share	54,915 Added 50.0%	54,915 Common Shares

Also insider at

ROIV

Roivant Sciences Ltd. Healthcare

KSM